European public procurement and grants data from official registers · Data as of 18 November 2026; updated daily.

Tenders

Blood products tenders in Czechia

Blood products tenders in Czechia: 321 listed on GranTender since 2024; 5 open now. The median awarded contract value is about €460,000 (241 contracts with a stated value). Buyers with the most tenders: Zdravotní ústav se sídlem v Ostravě (24), Fakultní nemocnice Olomouc (23) and Fakultní nemocnice Ostrava (21); suppliers with the most contract awards: Takeda Pharmaceuticals Czech Republic s.r.o. (100), Grifols s.r.o. (44) and LabMediaServis s.r.o. (30). Sources: Registr smluv, ISVZ (NIPEZ) and TED. In 2025 the median contract value was €520,000; 38% of contracts drew a single bid (18.8 bids on average). Data as of 18 November 2026; updated daily.

Tenders
321
Open tenders
5
Awards
630
Awarded value awarded
€367,592,061
Awarded value contract
€251,883,434
Awarded value framework ceiling
€59,721,149
Median contract value awarded
≈ €460,000
Median contract value contract
≈ €260,000
Median contract value framework ceiling
≈ €61,000
Average bids per contract
17.4
Tenders in 2025
124 +38% on 2024

Median: contracts with a stated value, rounded. Average bids: contracts where the number of bids is published.

Value kinds: awarded — the value in the award decision; contract — the value of the signed or amended contract; paid — the amount actually paid; framework ceiling — the maximum of a framework agreement, given with every winner, not money spent. Different kinds are never added together.

Open tenders

Latest tenders

TenderBuyerEstimated valueStatusPublished
Nákup - Léčivé přípravky intravenozní imunoglobuliny, část 1Fakultní nemocnice Brno—Awarded5 November 2026
Dodávky spotřebního materiálu s výpůjčkou multikomponentního separátoruKarlovarská krajská nemocnice a.s.CZK 7,500,000 (≈ €308,693)Open22 October 2026
Dodávky spotřebního materiálu s výpůjčkou multikomponentního separátoruKarlovarská krajská nemocnice a.s.CZK 7,500,000 (≈ €308,693)Open22 October 2026
Léčivý přípravek ATC skupiny B05AA01 s účinnou látkou ALBUMINNemocnice Pardubického kraje, a.s.CZK 19,140,000 (≈ €787,784)Open20 October 2026
Léčivý přípravek ATC skupiny B05AA01 s účinnou látkou ALBUMINNemocnice Pardubického kraje, a.s.CZK 19,140,000 (≈ €787,784)Open20 October 2026
Průběžné dodávky transfuzních přípravků včetně souvisejících služeb transfuzního oddělení pro Vojenskou nemocnici Olomouc 2026Vojenská nemocnice OlomoucCZK 15,375,920 (≈ €632,858)Open23 September 2026
Průběžné dodávky transfuzních přípravků včetně souvisejících služeb transfuzního oddělení pro Vojenskou nemocnici Olomouc 2026Vojenská nemocnice OlomoucCZK 15,375,920 (≈ €632,858)Closed23 September 2026
Průběžné dodávky transfuzních přípravků včetně souvisejících služeb transfuzního oddělení pro Vojenskou nemocnici Olomouc 2026Vojenská nemocnice OlomoucCZK 15,375,920 (≈ €632,858)Closed22 September 2026
Léčivé přípravky - Normální lidský imunoglobulin pro intravaskulární podáníZdravotní ústav se sídlem v Ostravě—Awarded13 September 2026
Kupní smlouva na normální lidský imunoglobulin pro intravenózní podání III.Všeobecná fakultní nemocnice v Praze—Awarded27 August 2026
Dodávka koňské krveStátní zdravotní ústavCZK 726 (≈ €30)Awarded25 August 2026
Imunoglubuliny SCIG VI. - HYQVIAInstitut klinické a experimentální medicínyCZK 6,800,000 (≈ €279,881)Awarded19 August 2026
Dodávky léků – Léčivá látka imunoglobuliny i.v. – ATC J06BA02Fakultní Thomayerova nemocniceCZK 87,120,000 (≈ €3,585,775)Awarded30 July 2026
NORMÁLNÍ LIDSKÝ IMUNOGLOBULIN PRO SUBKUTÁNNÍ PODÁNÍ S OBSAHOVOU LÁTKOU IMMUNOGLOBULINUMFakultní nemocnice Ostrava—Awarded20 July 2026
Imunoglobuliny IVIG VI.Institut klinické a experimentální medicínyCZK 58,812,000 (≈ €2,420,645)Awarded14 July 2026
Kupní smlouva k VZ-2026-000497 | Imunoglobulin normální lidský pro i.v. podání 2026Fakultní nemocnice Olomouc—Awarded3 July 2026
Rámcová kupní smlouva - DNS – Dodávka léčivých přípravků s obsahem LIDSKÉHO ALBUMINUKarlovarská krajská nemocnice a.s.—Awarded30 June 2026
TAKEDA - DNS květen_1/2026 imunoglobuliny II.Všeobecná fakultní nemocnice v Praze—Awarded26 June 2026
DYNAMICKÝ NÁKUPNÍ SYSTÉM PRO PRŮBĚŽNÉ A OPAKOVANÉ NÁKUPY LÉČIVÝCH PŘÍPRAVKŮ_Červen_8/2026 - NORMÁLNÍ LIDSKÝ IMUNOGLOBULIN PRO INTRAVENÓZNÍ PODÁNÍ III. opakovanáVšeobecná fakultní nemocnice v Praze—Awarded25 June 2026
DYNAMICKÝ NÁKUPNÍ SYSTÉM PRO PRŮBĚŽNÉ A OPAKOVANÉ NÁKUPY LÉČIVÝCH PŘÍPRAVKŮ_Červen_7/2026 -NORMÁLNÍ LIDSKÝ IMUNOGLOBULIN PRO INTRAVENÓZNÍ PODÁNÍ I. – OPAKOVANÁVšeobecná fakultní nemocnice v Praze—Awarded24 June 2026

Competition and prices

In 2025, half of the contracts were worth between €110,000 and €1.6 million, with a median of €520,000 (103 contracts with a stated awarded value). Contracts drew 18.8 bids on average (median 2) and 38% drew a single bid — based on 188 contracts with a known number of bids. Compared with 2024, in 2025 the median value rose 58% and the share of single-bid contracts rose from 30% to 38%. The usual procedures: open procedure (66%), other procedures (20%), direct award (10%) — of 137 tenders with a stated procedure.

The most contracts went to Takeda Pharmaceuticals Czech Republic s.r.o. (100), Grifols s.r.o. (44) and LabMediaServis s.r.o. (30) — together 28% of all contracts.

YearContractsMedian valueMiddle half of valuesBids on averageSingle bid
2024167€330,000€97,000 – €1.4 million15.830% (86)
2025261€520,000€110,000 – €1.6 million18.838% (188)
2026 (so far)187€340,000 (contract value)€37,000 – €1.2 million16.945% (117)
All years624€460,000€120,000 – €1.6 million17.439% (394)

Values: contracts with a stated value in EUR, each value kind on its own (awarded or contract value), approximate (±3 %). Bids: contracts of procedures with competition whose number of bids the source publishes (1–100 bids); the sources publish it for some contracts only (TED ≈ 3 in 4, Spain all, Poland about half, Italy few), so each figure states its base and is shown from 20 contracts. A contract counts in the year of its award (else of its tender). Figures as of 13 November 2026, recomputed every week.

Where you have a chance

Since 1 November 2024, 40% of the 320 contracts with a known number of bids had a single bid; the median was 3 bids. The number of bids is known for 320 of the 464 contracts from procedures with competition.

Buyers who often get few offers

The buyers below usually received one or two offers per contract — an offer from you would stand out.

In the last 12 months, 1 company won its first contract in our records here — 1% of the 145 contracts (our records start on 1 January 2024).

Contracts awarded since 1 November 2024 (the last 24 months). Bids as the source publishes them, 1 to 100 per contract, in procedures with competition only (a direct award has one offer by design). As of 13 November 2026.

Main CPV divisions

CPV codes of this topic

  • 33141500 Haematological consumables
  • 33651500 Immune sera and immunoglobulins

A tender belongs here when its main CPV code starts with one of these codes; a tender without a usable CPV code (or with a general one) is matched by words of its title. A tender may belong to up to three topics.

Blood products and immunoglobulins in neighbouring countries

Today, 5 tenders in the same niche are open in neighbouring countries.

Public tenders in the EU and the EEA are open to companies from every EU and EEA country on the same terms as local ones, and to companies from countries with a procurement agreement with the EU (such as Switzerland, the United Kingdom and Ukraine) for the contracts it covers. Open means the deadline has not passed (today's date). Neighbours: countries with a land border, a fixed link or a short sea crossing.

Expected soon5

ExpectedBuyerWhatWhy we expect itConfidence
now – Dec 2026
every year
Fakultní Thomayerova nemocniceBlood products and immunoglobulins
Dodávky léků – Léčivá látka imunoglobuliny k subkutánnímu podání – ATC J06BA01
Typical value: ≈ €1.1m
The buyer has published blood products tenders every year in November since 2024.
Earlier tenders: 11/2025, 12/2024
medium
now – Feb 2027
contract ends
Nemocnice Na FrantiškuBlood products and immunoglobulins
„Dodávka transfuzních přípravků 2024–2026 II“
Typical value: ≈ €420,000
The current contract with Ústřední vojenská nemocnice - Vojenská fakultní nemocnice Praha ends on 4 March 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 03/2024
high
now – Feb 2027
contract ends
Fakultní nemocnice BulovkaBlood products and immunoglobulins
PRŮBĚŽNÉ DODÁVKY TRANSFÚZNÍCH PŘÍPRAVKŮ II
Typical value: ≈ €3.8m
The current contract with Uherskohradišťská nemocnice a.s. ends on 24 March 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 03/2024
high
Feb – Jul 2027
contract ends
Nemocnice Kyjov, příspěvková organizaceBlood products and immunoglobulins
Léčivý přípravek s obsahem účinné látky SODNÁ SŮL ENOXAPARINU
Typical value: ≈ €190,000
The current contract with Sanofi s.r.o. ends on 15 August 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 05/2025
medium
Apr – Jul 2027
every year
Fakultní nemocnice OstravaBlood products and immunoglobulins
Činidla a spotřební materiál pro stanovení hladin volných lehkých a těžkých řetězců imunoglobulinů v séru a likvoru spojené s výpůjčkou imunoanalytického analyzátoru včetně UPS a dalšího potřebného zařízení.
Typical value: ≈ €220m
The buyer has published blood products tenders every year in May since 2024.
Earlier tenders: 06/2026, 06/2025, 04/2024
medium

Forecast from public data, not an announcement. Methodology.

Market reports

Blood products and immunoglobulins by city

Blood products and immunoglobulins in other countries

Blood products and immunoglobulins across Europe

Topics in Health, medical equipment and medicines

Questions and answers

Which blood products tenders in Czechia are open now?
5 of the 321 blood products tenders in Czechia listed on GranTender are open for bids. For example: Dodávky spotřebního materiálu s výpůjčkou multikomponentního separátoru; Dodávky spotřebního materiálu s výpůjčkou multikomponentního separátoru; Léčivý přípravek ATC skupiny B05AA01 s účinnou látkou ALBUMIN.
Where can I find blood products tenders in Czechia?
GranTender lists them in one place, from Registr smluv, ISVZ (NIPEZ) and TED, with their buyers, winners and contract values; 5 are open now. Search in one country at a time (the first 5 results) is free; search across all countries at once, full result lists, saved keywords with an e-mail once a week and exports come with a plan.
Who wins the most blood products tenders in Czechia?
By number of contracts won: Takeda Pharmaceuticals Czech Republic s.r.o. (100), Grifols s.r.o. (44), LabMediaServis s.r.o. (30).
Which buyers publish the most blood products tenders in Czechia?
By number of tenders: Zdravotní ústav se sídlem v Ostravě (24), Fakultní nemocnice Olomouc (23), Fakultní nemocnice Ostrava (21).
Which CPV codes belong to “Blood products and immunoglobulins”?
33141500 Haematological consumables; 33651500 Immune sera and immunoglobulins; plus tenders without a usable CPV code whose title names the topic.
How many bids do blood products tenders in Czechia receive on average?
In 2025, contracts drew 18.8 bids on average (median 2) and 38% drew a single bid — based on 188 contracts with a known number of bids.
How much are contracts for blood products tenders in Czechia worth?
In 2025, half of the contracts were worth between €110,000 and €1.6 million, with a median of €520,000 (103 contracts with a stated awarded value). Compared with 2024, in 2025 the median value rose 58% and the share of single-bid contracts rose from 30% to 38%.
Which procedures are used for blood products tenders in Czechia?
The usual procedures: open procedure (66%), other procedures (20%), direct award (10%) — of 137 tenders with a stated procedure.
Which buyers get few offers in blood products tenders in Czechia?
Since 1 November 2024, these buyers usually received one or two offers per contract: Zdravotní ústav se sídlem v Ostravě (median 1 bid over 16 contracts), Institut klinické a experimentální medicíny (median 1 bid over 13 contracts) and Fakultní Thomayerova nemocnice (median 1 bid over 8 contracts). Since 1 November 2024, 40% of the 320 contracts with a known number of bids had a single bid; the median was 3 bids.

CPV 2008 (Regulation (EC) No 213/2008), © European Union, Publications Office — via the eForms SDK, CC BY 4.0.